Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma

Purpose: Stomach adenocarcinoma (STAD) is one of the common cancers globally. Cuproptosis is a newly identified cell death pattern. The role of cuproptosis-associated lncRNAs in STAD is unknown.Methods: STAD patient data from TCGA were used to identify prognostic lncRNAs by Cox regression and LASSO....

Full description

Bibliographic Details
Main Authors: Wei Yu, Hongqi Huo, Zhixin You, Rong Lu, Tianci Yao, Jing Huang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.982888/full
_version_ 1828177568450215936
author Wei Yu
Hongqi Huo
Zhixin You
Rong Lu
Tianci Yao
Jing Huang
author_facet Wei Yu
Hongqi Huo
Zhixin You
Rong Lu
Tianci Yao
Jing Huang
author_sort Wei Yu
collection DOAJ
description Purpose: Stomach adenocarcinoma (STAD) is one of the common cancers globally. Cuproptosis is a newly identified cell death pattern. The role of cuproptosis-associated lncRNAs in STAD is unknown.Methods: STAD patient data from TCGA were used to identify prognostic lncRNAs by Cox regression and LASSO. A nomogram was constructed to predict patient survival. The biological profiles were evaluated through GO and KEGG.Results: We identified 298 cuproptosis-related lncRNAs and 13 survival-related lncRNAs. Patients could be categorized into either high risk group or low risk group with 9-lncRNA risk model with significantly different survival time (p < 0.001). ROC curve and nomogram confirmed the 9-lncRNA risk mode had good prediction capability. Patients in the lower risk score had high gene mutation burden. We also found that patients in the two groups might respond differently to immune checkpoint inhibitors and some anti-tumor compounds.Conclusion: The nomogram with 9-lncRNA may help guide treatment of STAD. Future clinical studies are necessary to verify the nomogram.
first_indexed 2024-04-12T05:00:43Z
format Article
id doaj.art-d883e3fb24714cf6803b79c22f2d348d
institution Directory Open Access Journal
issn 1664-8021
language English
last_indexed 2024-04-12T05:00:43Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Genetics
spelling doaj.art-d883e3fb24714cf6803b79c22f2d348d2022-12-22T03:47:01ZengFrontiers Media S.A.Frontiers in Genetics1664-80212022-09-011310.3389/fgene.2022.982888982888Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinomaWei Yu0Hongqi Huo1Zhixin You2Rong Lu3Tianci Yao4Jing Huang5Department of Pharmacy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, ChinaNuclear Medicine Department, HanDan Central Hospital, Handan, ChinaNuclear Medicine Department, HanDan Central Hospital, Handan, ChinaDepartment of Laboratory Medicine, The First Affiliated Hospital of Xiamen University, Xiamen Key Laboratory of Genetic Testing, School of Medicine, Xiamen University, Xiamen, ChinaDepartment of Pharmacy, The First Affiliated Hospital of Xiamen University, Xiamen, ChinaDepartment of Pharmacy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, ChinaPurpose: Stomach adenocarcinoma (STAD) is one of the common cancers globally. Cuproptosis is a newly identified cell death pattern. The role of cuproptosis-associated lncRNAs in STAD is unknown.Methods: STAD patient data from TCGA were used to identify prognostic lncRNAs by Cox regression and LASSO. A nomogram was constructed to predict patient survival. The biological profiles were evaluated through GO and KEGG.Results: We identified 298 cuproptosis-related lncRNAs and 13 survival-related lncRNAs. Patients could be categorized into either high risk group or low risk group with 9-lncRNA risk model with significantly different survival time (p < 0.001). ROC curve and nomogram confirmed the 9-lncRNA risk mode had good prediction capability. Patients in the lower risk score had high gene mutation burden. We also found that patients in the two groups might respond differently to immune checkpoint inhibitors and some anti-tumor compounds.Conclusion: The nomogram with 9-lncRNA may help guide treatment of STAD. Future clinical studies are necessary to verify the nomogram.https://www.frontiersin.org/articles/10.3389/fgene.2022.982888/fullrisk scoreprognosiscuproptosisimmunetumor
spellingShingle Wei Yu
Hongqi Huo
Zhixin You
Rong Lu
Tianci Yao
Jing Huang
Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
Frontiers in Genetics
risk score
prognosis
cuproptosis
immune
tumor
title Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
title_full Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
title_fullStr Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
title_full_unstemmed Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
title_short Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
title_sort identification of cuproptosis associated incrnas signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma
topic risk score
prognosis
cuproptosis
immune
tumor
url https://www.frontiersin.org/articles/10.3389/fgene.2022.982888/full
work_keys_str_mv AT weiyu identificationofcuproptosisassociatedincrnassignatureandestablishmentofanovelnomogramforprognosisofstomachadenocarcinoma
AT hongqihuo identificationofcuproptosisassociatedincrnassignatureandestablishmentofanovelnomogramforprognosisofstomachadenocarcinoma
AT zhixinyou identificationofcuproptosisassociatedincrnassignatureandestablishmentofanovelnomogramforprognosisofstomachadenocarcinoma
AT ronglu identificationofcuproptosisassociatedincrnassignatureandestablishmentofanovelnomogramforprognosisofstomachadenocarcinoma
AT tianciyao identificationofcuproptosisassociatedincrnassignatureandestablishmentofanovelnomogramforprognosisofstomachadenocarcinoma
AT jinghuang identificationofcuproptosisassociatedincrnassignatureandestablishmentofanovelnomogramforprognosisofstomachadenocarcinoma